[8] Drmic, D., Kolenc, D., Ilic, S., & Sikiric, P
Cigarette smoking and liver diseases
Others don't budge
2 The FDA emphasizes that it does not evaluate compounded drugs for safety, effectiveness, or quality, and that they are not the same as the FDA-approved versions
It should be noted, however, that these are few and preliminary studies that, on the one hand, provide valuable and promising data, but on the other hand, the results are limited and have not yet been sufficiently confirmed
An evaluation of pegvisomant as long-term monotherapy in acromegalic patients from the global safety surveillance study ACROSTUDY reported increases or increases/decreases in the tumor sizes in 12 of 542 subjects (2.2%)